We are live on ! Find out more
AMPH icon

Amphastar Pharmaceuticals
AMPH

133 hedge funds and large institutions have $471M invested in Amphastar Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 58 increasing their positions, 41 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

41% more repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 41

3% more capital invested

Capital invested by funds: $458M → $471M (+$13.2M)

0% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 16

0.48% less ownership

Funds ownership: 47.91% → 47.43% (-0.48%)

1% less funds holding

Funds holding: 135 → 133 (-2)

96% less call options, than puts

Call options by funds: $21K | Put options by funds: $517K

Holders
133
Holders Change
-2
Holders Change %
-1.48%
% of All Funds
2.89%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
58
Reduced
41
Closed
16
Calls
$21K
Puts
$517K
Net Calls
-$496K
Net Calls Change
-$717K

Top Buyers

Rank Fund Capital Flow
1
N
Nuveen
North Carolina
+$12M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
+$3.39M
3
Federated Hermes
Federated Hermes
Pennsylvania
+$3.24M
4
Renaissance Technologies
Renaissance Technologies
New York
+$3.06M
5
MSL
Mackay Shields LLC
New York
+$2.44M

Top Sellers

Rank Fund Capital Flow
1
Invesco
Invesco
Georgia
-$12.3M
2
Morgan Stanley
Morgan Stanley
New York
-$4.57M
3
Goldman Sachs
Goldman Sachs
New York
-$3.33M
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$2.23M
5
SAM
Sawgrass Asset Management
Florida
-$1.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
Ohio Public Employees Retirement System (OPERS)
76
Ohio Public Employees Retirement System (OPERS)
Ohio
$450K – – –
AWM
77
AE Wealth Management
Kansas
$406K +$193K +9,227 +92%
SS
78
Simplicity Solutions
Minnesota
$394K +$170K +8,118 +77%
AQR Capital Management
79
AQR Capital Management
Connecticut
$391K -$65K -3,108 -14%
ProShare Advisors
80
ProShare Advisors
Maryland
$390K -$41.9K -2,005 -10%
MIM
81
MetLife Investment Management
New Jersey
$384K – – –
Citigroup
82
Citigroup
New York
$378K -$315K -15,058 -46%
SSA
83
Schonfeld Strategic Advisors
New York
$358K -$554K -26,500 -61%
VOYA Investment Management
84
VOYA Investment Management
Georgia
$332K +$5.12K +245 +2%
State of Tennessee, Department of Treasury
85
State of Tennessee, Department of Treasury
Tennessee
$321K +$10.3K +493 +3%
USAA
86
United Services Automobile Association
Texas
$321K +$113K +5,409 +55%
RHBC
87
R.H. Bluestein & Co
Michigan
$317K – – –
Millennium Management
88
Millennium Management
New York
$312K -$120K -5,746 -28%
LPL Financial
89
LPL Financial
California
$312K +$309K +14,773 New
New York State Teachers Retirement System (NYSTRS)
90
New York State Teachers Retirement System (NYSTRS)
New York
$308K – – –
Public Employees Retirement Association of Colorado
91
Public Employees Retirement Association of Colorado
Colorado
$290K -$357K -17,061 -55%
OPERF
92
Oregon Public Employees Retirement Fund
Oregon
$287K +$4.18K +200 +1%
LCM
93
Laurion Capital Management
New York
$283K -$119K -5,682 -30%
LSERS
94
Louisiana State Employees Retirement System
Louisiana
$267K +$6.27K +300 +2%
MLICM
95
Metropolitan Life Insurance Company (MetLife)
New York
$265K – – –
COPPSERS
96
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$255K +$4.66K +223 +2%
SOADOR
97
State of Alaska Department of Revenue
Alaska
$253K +$7.23K +346 +3%
MAM
98
Meeder Asset Management
Ohio
$249K -$76.4K -3,655 -24%
MSA
99
Mason Street Advisors
Wisconsin
$249K +$14.2K +680 +6%
PP
100
Paloma Partners
Connecticut
$248K -$135K -6,473 -36%
2 3
4
5 6

AMPH Hedge Fund Activity: Q2 2019 in Review

133 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Amphastar Pharmaceuticals (AMPH) for Q2 2019, worth a combined $471M — up 2.9% from $458M a quarter earlier.

Fund positioning in AMPH was balanced in Q2 2019: 16 funds opened new positions, 16 closed out, 58 added to existing stakes and 41 trimmed.

The largest buyer was Nuveen, opening a new position worth an estimated $12M. The largest seller was Invesco, cutting an estimated $12.3M.

  • 133 institutional investors held Amphastar Pharmaceuticals (AMPH) as of Q2 2019, down from 135 in Q1 2019.
  • Funds reported $471M of Amphastar Pharmaceuticals stock for Q2 2019, up 2.9% quarter-over-quarter.
  • 16 funds opened new Amphastar Pharmaceuticals positions in Q2 2019 and 16 closed out, a net change of 0 holders.
  • The largest Amphastar Pharmaceuticals buyer in Q2 2019 was Nuveen, an estimated $12M added.
  • The largest Amphastar Pharmaceuticals seller in Q2 2019 was Invesco, an estimated $12.3M sold.

Based on aggregated 13F filings for Q2 2019.